Adamis Pharmaceuticals Corp (ADMP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- GDPH140821D
- Pages: 37
- October 2018
- Total Views:1142
- Region : North America
- GlobalData
- Equity Research Report
Details
Summary
Adamis Pharmaceuticals Corp (Adamis), formerly Cellegy Pharmaceuticals Inc, is a biopharmaceutical company that develops therapies in areas of respiratory disease and allergy. The company offers pipeline product, epinephrine pre-filled syringe is developed for anaphylactic reactions such as insect stings, foods, medications and latex. It also offers pipeline products such as APC-2000 for the treatment of bronchospasms; APC-1000 and APC-4000 for the treatment of asthma and chronic obstructive pulmonary disease; and steroid product for the treatment of allergic rhinitis. The company has operations in Phoenix and San Diego. Adamis is headquartered in San Diego, California, the US.
Adamis Pharmaceuticals Corp (ADMP)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Content
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Adamis Pharmaceuticals Corp, Medical Devices Deals, 2012 to YTD 2018 9
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Adamis Pharma Enters Into Licensing Agreement With 3M Company For Taper Dry Powder Inhaler Technology 11
Equity Offering 12
Adamis Pharma Rises USD40.2 Million in Public Offering of Shares 12
Adamis Pharma Raises USD17.3 Million in Public Offering of Shares 13
Adamis Pharma Raises USD11 Million in Private Placement of Units 15
Adamis Pharma Raises USD5 Million in Private Placement of Preferred Stock 17
Adamis Pharma Raises USD5 Million in Private Placement of Preferred Stock 18
Adamis Pharma Raises USD11.5 Million in Public Offering of Shares 19
Adamis Pharma Raises USD5 Million in Private Placement of Preferred Stock 21
Adamis Pharma Completes Underwriters Exercise Of Over-Allotment Option Of Public Offering Of Shares For USD 25.5 Million 22
Adamis Pharma Completes Final Tranche Of Private Placement Of Shares For USD 0.5 Million 23
Debt Offering 24
Adamis Pharma Completes Private Placement Of Debentures For USD 0.6 Million 24
Adamis Pharma Completes Private Placement Of Senior Convertible Note For USD 0.5 Million 25
Adamis Pharma Completes Private Placement Of Senior Convertible Note Due 2013 For USD 1 Million 26
Adamis Pharmaceuticals Corp-Key Competitors 27
Adamis Pharmaceuticals Corp-Key Employees 28
Adamis Pharmaceuticals Corp-Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Financial Announcements 30
Aug 10, 2018: Adamis Pharmaceuticals announces second quarter 2018 financial results and business update 30
May 10, 2018: Adamis Pharmaceuticals Announces First Quarter 2018 Financial Results and Business Update 32
Product Approvals 33
Jul 23, 2018: Adamis Pharmaceuticals adds sublingual erectile dysfunction product candidate to its pipeline 33
Dec 04, 2017: Adamis Pharmaceuticals Announces Submission of Investigational New Drug Application to the FDA for New Product Candidate for the Treatment of Opioid Overdose 34
Other Significant Developments 35
Mar 15, 2018: Adamis Pharmaceuticals Discusses 2017 Highlights and Business Update 35
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37
List Of Figure
List of Figures
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Adamis Pharmaceuticals Corp, Medical Devices Deals, 2012 to YTD 2018 9
List Of Table
List of Tables
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Adamis Pharmaceuticals Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Adamis Pharmaceuticals Corp, Medical Devices Deals, 2012 to YTD 2018 9
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Adamis Pharma Enters Into Licensing Agreement With 3M Company For Taper Dry Powder Inhaler Technology 11
Adamis Pharma Rises USD40.2 Million in Public Offering of Shares 12
Adamis Pharma Raises USD17.3 Million in Public Offering of Shares 13
Adamis Pharma Raises USD11 Million in Private Placement of Units 15
Adamis Pharma Raises USD5 Million in Private Placement of Preferred Stock 17
Adamis Pharma Raises USD5 Million in Private Placement of Preferred Stock 18
Adamis Pharma Raises USD11.5 Million in Public Offering of Shares 19
Adamis Pharma Raises USD5 Million in Private Placement of Preferred Stock 21
Adamis Pharma Completes Underwriters Exercise Of Over-Allotment Option Of Public Offering Of Shares For USD 25.5 Million 22
Adamis Pharma Completes Final Tranche Of Private Placement Of Shares For USD 0.5 Million 23
Adamis Pharma Completes Private Placement Of Debentures For USD 0.6 Million 24
Adamis Pharma Completes Private Placement Of Senior Convertible Note For USD 0.5 Million 25
Adamis Pharma Completes Private Placement Of Senior Convertible Note Due 2013 For USD 1 Million 26
Adamis Pharmaceuticals Corp, Key Competitors 27
Adamis Pharmaceuticals Corp, Key Employees 28
Adamis Pharmaceuticals Corp, Subsidiaries 29
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
Adamis Pharmaceuticals Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Company Profile
Company Profile Title
Summary
Adamis Pharmaceuticals Corp (Adamis), formerly Cellegy Pharmaceuticals Inc, is a biopharmaceutical company that develops therapies in areas of respiratory disease and allergy. The company offers pipeline product, epinephrine pre-filled syringe is developed for anaphylactic reactions such as insect stings, foods, medications and latex. It also offers pipeline products such as APC-2000 for the treatment of bronchospasms; APC-1000 and APC-4000 for the treatment of asthma and chronic obstructive pulmonary disease; and steroid product for the treatment of allergic rhinitis. The company has operations in Phoenix and San Diego. Adamis is headquartered in San Diego, California, the US.
Adamis Pharmaceuticals Corp (ADMP)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Adamis Pharmaceuticals Corp, Medical Devices Deals, 2012 to YTD 2018 9
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Adamis Pharma Enters Into Licensing Agreement With 3M Company For Taper Dry Powder Inhaler Technology 11
Equity Offering 12
Adamis Pharma Rises USD40.2 Million in Public Offering of Shares 12
Adamis Pharma Raises USD17.3 Million in Public Offering of Shares 13
Adamis Pharma Raises USD11 Million in Private Placement of Units 15
Adamis Pharma Raises USD5 Million in Private Placement of Preferred Stock 17
Adamis Pharma Raises USD5 Million in Private Placement of Preferred Stock 18
Adamis Pharma Raises USD11.5 Million in Public Offering of Shares 19
Adamis Pharma Raises USD5 Million in Private Placement of Preferred Stock 21
Adamis Pharma Completes Underwriters Exercise Of Over-Allotment Option Of Public Offering Of Shares For USD 25.5 Million 22
Adamis Pharma Completes Final Tranche Of Private Placement Of Shares For USD 0.5 Million 23
Debt Offering 24
Adamis Pharma Completes Private Placement Of Debentures For USD 0.6 Million 24
Adamis Pharma Completes Private Placement Of Senior Convertible Note For USD 0.5 Million 25
Adamis Pharma Completes Private Placement Of Senior Convertible Note Due 2013 For USD 1 Million 26
Adamis Pharmaceuticals Corp-Key Competitors 27
Adamis Pharmaceuticals Corp-Key Employees 28
Adamis Pharmaceuticals Corp-Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Financial Announcements 30
Aug 10, 2018: Adamis Pharmaceuticals announces second quarter 2018 financial results and business update 30
May 10, 2018: Adamis Pharmaceuticals Announces First Quarter 2018 Financial Results and Business Update 32
Product Approvals 33
Jul 23, 2018: Adamis Pharmaceuticals adds sublingual erectile dysfunction product candidate to its pipeline 33
Dec 04, 2017: Adamis Pharmaceuticals Announces Submission of Investigational New Drug Application to the FDA for New Product Candidate for the Treatment of Opioid Overdose 34
Other Significant Developments 35
Mar 15, 2018: Adamis Pharmaceuticals Discusses 2017 Highlights and Business Update 35
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37
List Of Figure
List of Figures
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Adamis Pharmaceuticals Corp, Medical Devices Deals, 2012 to YTD 2018 9
List Of Table
List of Tables
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Adamis Pharmaceuticals Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Adamis Pharmaceuticals Corp, Medical Devices Deals, 2012 to YTD 2018 9
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Adamis Pharma Enters Into Licensing Agreement With 3M Company For Taper Dry Powder Inhaler Technology 11
Adamis Pharma Rises USD40.2 Million in Public Offering of Shares 12
Adamis Pharma Raises USD17.3 Million in Public Offering of Shares 13
Adamis Pharma Raises USD11 Million in Private Placement of Units 15
Adamis Pharma Raises USD5 Million in Private Placement of Preferred Stock 17
Adamis Pharma Raises USD5 Million in Private Placement of Preferred Stock 18
Adamis Pharma Raises USD11.5 Million in Public Offering of Shares 19
Adamis Pharma Raises USD5 Million in Private Placement of Preferred Stock 21
Adamis Pharma Completes Underwriters Exercise Of Over-Allotment Option Of Public Offering Of Shares For USD 25.5 Million 22
Adamis Pharma Completes Final Tranche Of Private Placement Of Shares For USD 0.5 Million 23
Adamis Pharma Completes Private Placement Of Debentures For USD 0.6 Million 24
Adamis Pharma Completes Private Placement Of Senior Convertible Note For USD 0.5 Million 25
Adamis Pharma Completes Private Placement Of Senior Convertible Note Due 2013 For USD 1 Million 26
Adamis Pharmaceuticals Corp, Key Competitors 27
Adamis Pharmaceuticals Corp, Key Employees 28
Adamis Pharmaceuticals Corp, Subsidiaries 29
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
Adamis Pharmaceuticals Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Ask A Question
Our Team Will Assist You in What You Are Looking For
or 
: +91 98100 26150
: ankurgupta1984
Related Reports
Page 130 | 
December 2020
Page 130 | December 2020
Page 131 | November 2020
Page 95 | November 2020
Page 96 | August 2020